Get started
Author

Daniela De Lorenzo

MYD88 L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study
2021 · Andrés J. M. Ferreri, Teresa Calimeri, et al. · British Journal of Haematology · 106
PDF
ROR1 contributes to melanoma cell growth and migration by regulating N‐cadherin expression via the PI3K/Akt pathway
2015 · Natalia Brenda Fernández, Daniela Lorenzo, et al. · Molecular Carcinogenesis · 58
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial
2020 · Andrés J. M. Ferreri, Teresa Calimeri, et al. · Blood Advances · 37
PDF
Early Increases in Superantigen-Specific Foxp3+Regulatory T Cells during Mouse Mammary Tumor Virus Infection
2008 · Gabriel Cabrera, Dalia Burzyn, et al. · Journal of Virology · 18
Rationale and Protocol of AIRC IG-13218, Short-Term Radiotherapy for Early Prostate Cancer with Concomitant Boost to the Dominant Lesion
2016 · Giorgia Timon, Delia Ciardo, et al. · Tumori Journal · 16
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion: ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218
2018 · Giorgia Timon, Delia Ciardo, et al. · British Journal of Radiology · 12
Feasibility of lymphoscintigraphy for sentinel node identification after neo-adjuvant therapy.
2017 · Giovanni Corso, Chiara Maria Grana, et al. · PubMed · 9
Long‐lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B‐cell lymphoma who are not eligible for or failed autologous transplantation
2020 · Andrés J. M. Ferreri, Marianna Sassone, et al. · Hematological Oncology · 8
A B-Cell Superantigen Induces the Apoptosis of Murine and Human Malignant B Cells
2016 · Daniela Lorenzo, Alejandra Duarte, et al. · PLoS ONE · 7
PDF
Superantigens Increase the Survival of Mice Bearing T Cell Lymphomas by Inducing Apoptosis of Neoplastic Cells
2010 · Juliana Mundiñano, Paula M. Berguer, et al. · PLoS ONE · 6
PDF
Clinical Relevance of MYD88 L265P Mutation and Interleukin-10 Level in Cerebrospinal Fluid of Patients with Both Newly Diagnosed and Relapsed Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
2019 · Andres JM Ferreri, Teresa Calimeri, et al. · Blood · 1
Author response for "LONG-LASTING EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR OR FAILED AUTOLOGOUS TRANSPLANTATION"
2020 · Andrés J. M. Ferreri, Marianna Sassone, et al. · Publons reviews and discussion
Blood-Brain Barrier Permeabilization with Engineered Tumor Necrosis Factor-α Followed by R-CHOP Is an Active and Safe Salvage Therapy in Primary CNS Lymphoma
2020 · Andrés Ferreri, Teresa Calimeri, et al. · SSRN Electronic Journal
Long‐term Efficacy and Safety of Lenalidomide Maintenance in Patients With Relapsed Diffuse Large B‐cell Lymphoma Who Are Not Eligible for Autologous Transplantation (asct)
2019 · A.J. Ferreri, M.C. Sassone, et al. · Hematological Oncology
Multicenter Phase II Trial Addressing Lenalidomide Maintenance in Patients with Relapsed Diffuse Large B-Cell Lymphoma (rDLBCL) Who Are Not Eligible for Autologous Stem Cell Transplantation (ASCT): Efficacy and Safety Results after a Median Follow-up of Five Years
2018 · Andres JM Ferreri, Marianna Sassone, et al. · Blood
Works count: 15
Citation count: 278
H-index: 8
I10-index: 6
Year
Topic
Type